Země: Nový Zéland
Jazyk: angličtina
Zdroj: Medsafe (Medicines Safety Authority)
Clindamycin phosphate 178.22 mg/mL Equivalent to clindamycin base 150 mg/mL; ; ;
Pfizer New Zealand Limited
Clindamycin phosphate 178.22 mg/mL (Equivalent to clindamycin base 150 mg/mL)
600mg/4mL
Solution for injection
Active: Clindamycin phosphate 178.22 mg/mL Equivalent to clindamycin base 150 mg/mL Excipient: Benzyl alcohol Disodium edetate dihydrate Hydrochloric acid Sodium hydroxide Water for injection
Ampoule, 4mL, 1 dose unit
Prescription
Prescription
Zhejiang Hisoar Pharmaceutical Co. Ltd
Clindamycin phosphate has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, staphylococci and pneumococci: 1. Upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever.
Package - Contents - Shelf Life: Ampoule, 4mL - 1 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Ampoule, 4mL - 10 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)
1974-07-12
DALACIN ® C INJECTION 1 DALACIN® C INJECTION _Clindamycin phosphate _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Dalacin C Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given Dalacin C Injection against the benefits this medicine is expected to have for you. Dalacin C Injection should only be given to you by a health professional. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT DALACIN C INJECTION IS USED FOR Dalacin C Injection is an antibiotic. It is used to treat infections in different parts of the body caused by bacteria. This medicine works by killing or stopping the growth of bacteria causing your infection. It will not work against viral infections such as colds or flu. Dalacin C Injection is recommended for patients who are allergic to penicillin. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY DALACIN C INJECTION HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed Dalacin C Injection for another reason. This medicine is available only with a doctor's prescription. Dalacin C Injection is not addictive. BEFORE YOU ARE GIVEN DALACIN C INJECTION _WHEN YOU MUST NOT BE GIVEN _ _IT _ YOU MUST NOT BE GIVEN DALACIN C INJECTION IF YOU HAVE AN ALLERGY TO: • clindamycin or lincomycin • any of the other ingredients listed at the end of this leaflet (see 'Product Description'). Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin. YOU SHOULD NOT BE GIVEN THIS MEDICINE IF THE EXPIRY DATE PRINTED ON THE PACK HAS PASSED OR IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING. If it has expired or is d Přečtěte si celý dokument
Version: pfddacpi10122 Supersedes: pfddacpi10821 Page 1 of 15 NEW ZEALAND DATA SHEET 1. PRODUCT NAME DALACIN ® C 600 mg/4 mL solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 mL of DALACIN C solution contains 178.22 mg/mL clindamycin phosphate equivalent to 150 mg clindamycin. Excipients with known effect: Each 1 mL of solution contains 9.45 mg benzyl alcohol. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear, colourless, sterile solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clindamycin phosphate has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of Gram- positive bacteria such as Streptococci, Staphylococci and Pneumococci: 1. Upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever. 2. Lower respiratory infections including bronchitis, pneumonia, empyema and lung abscess. 3. Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections. For specific skin and soft tissue infections like erysipelas and paronychia (panaritium). 4. Bone and joint infections including osteomyelitis and septic arthritis. 5. Pelvic infections including endometritis, cellulitis, vaginal cuff infection tubo-ovarian abscesses salpingitis and pelvic inflammatory disease when given in conjunction with an antibiotic of appropriate Gram-negative aerobic spectrum. In cases of cervicitis due to _Chlamydia_ _trachomatis_ , monotherapy with clindamycin has been shown to be effective in eradicating the organism. 6. Intra-abdominal infections including peritonitis and abdominal abscess when given in conjunction with an antibiotic of appropriate Gram-negative aerobic spectrum. Version: pfddacpi10122 Supersedes: pfddacpi10821 Page 2 of 15 7. Septicaemia and endocarditis - the effectiveness of clindamycin in the treatment of selected cases of endocarditis has been do Přečtěte si celý dokument